Increased_VBN
glucocorticoid_NN
responsiveness_NN
of_IN
CD4_NN
+_CC
T-cell_NN
clonal_JJ
lines_NNS
grown_VBN
in_IN
serum-free_JJ
media_NNS
._.

CEM-C7_NN
,_,
a_DT
human_JJ
leukemic_JJ
CD4_NN
+_CC
T-lymphocyte_NN
cell_NN
line_NN
and_CC
three_CD
of_IN
its_PRP$
subclones_NNS
,_,
CEM-4R4_NN
,_,
CEM-3R43_NN
,_,
and_CC
ICR-27_NN
,_,
previously_RB
cultured_VBN
in_IN
a_DT
medium_NN
supplemented_VBN
with_IN
5_CD
to_TO
10_CD
%_NN
fetal_JJ
bovine_JJ
serum_NN
,_,
have_VBP
been_VBN
adapted_VBN
to_TO
serum-free_JJ
media_NNS
._.

The_DT
best_JJS
medium_NN
of_IN
those_DT
tested_VBN
was_VBD
RPMI_NN
1640_CD
supplemented_VBN
with_IN
5_CD
micrograms\/ml_NNS
each_DT
transferrin_NN
and_CC
insulin_NN
+_CC
5_CD
ng\/ml_NN
sodium_NN
selenite_NN
+_CC
\/_NN
-_:
0.1_CD
%_NN
bovine_JJ
serum_NN
albumin_NN
._.

While_IN
growing_VBG
either_CC
with_IN
or_CC
without_IN
albumin_NN
,_,
the_DT
several_JJ
clonal_JJ
lines_NNS
of_IN
CEM_NN
cells_NNS
displayed_VBD
growth_NN
similar_JJ
to_TO
serum-supplemented_JJ
cultures_NNS
._.

Cell_NN
proliferation_NN
of_IN
CEM-C7_NN
cells_NNS
cultured_VBN
in_IN
both_DT
serum-free_JJ
media_NNS
has_VBZ
been_VBN
sustained_JJ
for_IN
3_CD
mo._NN
with_IN
culture_NN
doubling_VBG
times_NNS
of_IN
about_RB
25_CD
h_NN
for_IN
both_CC
serum-supplemented_JJ
and_CC
serum-free_JJ
cultures_NNS
-LRB-_-LRB-
viability_NN
greater_JJR
than_IN
or_CC
equal_JJ
to_TO
90_CD
%_NN
-RRB-_-RRB-
._.

Cell_NN
morphology_NN
remained_VBD
essentially_RB
the_DT
same_JJ
in_IN
serum-free_JJ
or_CC
serum_NN
containing_VBG
media_NNS
._.

The_DT
expression_NN
of_IN
CD4_NN
,_,
a_DT
marker_NN
for_IN
T-derived_JJ
lymphoid_JJ
cells_NNS
,_,
was_VBD
not_RB
significantly_RB
different_JJ
in_IN
serum-free_JJ
medium_NN
._.

When_WRB
grown_VBN
in_IN
serum-free_JJ
medium_NN
,_,
CEM-C7_NN
cells_NNS
exhibited_VBD
increased_VBN
steroid_NN
responsiveness_NN
as_IN
evidenced_VBN
by_IN
increased_VBN
glucocorticoid_NN
receptor_NN
binding_NN
sites_NNS
,_,
increased_VBN
induction_NN
of_IN
glutamine_NN
synthetase_NN
,_,
and_CC
cell_NN
lysis_NN
at_IN
lower_JJR
concentrations_NNS
of_IN
steroid_NN
._.

Receptor_NN
mutant_NN
subclones_NNS
of_IN
CEM-C7_NN
,_,
which_WDT
are_VBP
proven_VBN
to_TO
be_VB
completely_RB
unresponsive_JJ
to_TO
micromolar_JJ
concentrations_NNS
of_IN
dexamethasone_NN
when_WRB
grown_VBN
in_IN
serum-supplemented_JJ
medium_NN
,_,
become_VBP
partially_RB
sensitive_JJ
to_TO
the_DT
hormone_NN
after_IN
growth_NN
in_IN
defined_VBN
medium_NN
._.

The_DT
increased_VBN
sensitivity_NN
of_IN
CEM-C7_NN
cells_NNS
and_CC
its_PRP$
subclones_NNS
to_TO
dexamethasone_NN
in_IN
serum-free_JJ
medium_NN
returned_VBD
to_TO
previous_JJ
levels_NNS
when_WRB
these_DT
cells_NNS
were_VBD
recultured_VBN
in_IN
serum-containing_JJ
medium_NN
._.

Our_PRP$
results_NNS
suggest_VBP
that_IN
substances_NNS
in_IN
serum_NN
influence_VBP
steroid_NN
effects_NNS
on_IN
these_DT
cells_NNS
and_CC
that_IN
the_DT
molecular_JJ
details_NNS
of_IN
glucocorticoid_NN
hormone_NN
action_NN
may_MD
be_VB
pursued_VBN
more_RBR
precisely_RB
in_IN
a_DT
clearly_RB
defined_VBN
culture_NN
medium_NN
._.

